atazanavir

This page contains recent news articles, when available, and an overview of atazanavir but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Does Switching to Norvir-Boosted Reyataz Spare the Heart?  -  ‎Dec 31, 2009‎
New research suggests that the protease inhibitor (PI) Reyataz (atazanavir), when boosted by low-dose Norvir (ritonavir), might not improve cardiovascular ... AIDSmeds.com HIV/AIDS Treatment News

Reyataz and Sustiva Co-Pay Programs Expanded  -  ‎Dec 18, 2009‎
...now begin with the first dollar a person pays a pharmacy or mail-order service for his or her Reyataz (atazanavir) or Sustiva (efavirenz) prescriptions. ... AIDSmeds.com HIV/AIDS Treatment News

UNITAID approves patent pool for HIV drugs  -  ‎Dec 15, 2009‎
In second-line treatment there will be interest in creating fixed dose products that contain the protease inhibitor atazanavir and two nucleoside analogues, ... Aidsmap

Study Identifies Viread And Emtriva As The Preferred Initial Treatment For HIV ...  -  ‎Dec 10, 2009‎
Emtriva or Ziagen and Epivir along with either Norvir (ritonavir)-boosted Reyataz (atazanavir), a protease inhibitor, or Sustiva (efavirenz), an NNRTI. ... The AIDS Beacon (blog)

UNITAID Drug Patent Pool Implementation Hinges On Board  -  ‎Dec 11, 2009‎
An MSF pharmacist in Brazil was quoted as saying in that country, one newer drug, atazanavir, “is so expensive that it is eating up most of the government's ... Intellectual Property Watch (blog)

MinSalud garantiza tratamientos de VIH/SIDA hasta enero de 2010  -  ‎Dec 9, 2009‎
Posteriormente, el martes, entregamos otro de los antirretrovirales ya más tardar el próximo viernes debemos estar entregando el atazanavir, que es el único ... El Nacional (Venezuela)

FDA核准Etravirine用於多é‡?抗藥性HIV  -  ‎Dec 9, 2009‎
Etravirineä¸?應和NNRTIsã€?蛋白酶抑制劑未併用ritonavir時ã€?ritonavir-強化之tipranavirã€?fosamprenavir或atazanavirå?Œæ™‚æœ?用。Ritonavir-強化之lopinavir應å°?心使用。 ... 臺灣新浪網

FDA Approves Labeling Update for REYATAZ® (atazanavir sulfate) Capsules to ...  -  ‎Nov 5, 2009‎
Grade 2-4 treatment-related adverse events that occurred in 2% or greater of patients on the REYATAZ ® (atazanavir sulfate)/r regimen, regardless of ... WELT ONLINE

No Gender Differences Seen With Atazanavir Treatment for HIV Infection ...  -  ‎Nov 1, 2009‎
She and her team pooled data from 4 studies of unboosted atazanavir, and identified 286 women among the 787 subjects in the atazanavir-containing arms. ... DG News

Concert: protease inhibitor holds potential to be prescribed un-boosted  -  ‎Nov 10, 2009‎
CTP-518 is a novel HIV PI developed from Concert's deuterium chemistry platform by replacing certain key hydrogen atoms of atazanavir with deuterium. ... Trading Markets (press release)

Concert Pharmaceuticals Initiates Phase 1b Clinical Trial Of CTP-518, Protease ...  -  ‎Nov 11, 2009‎
CTP-518 is a novel HIV protease inhibitor developed from Concert's deuterium chemistry platform by replacing certain key hydrogen atoms of atazanavir with ... Medical News Today (press release)

Concert Starts HIV Trial, Bags $12M From Glaxo to Help Challenge Gilead's Once ...  -  ‎Nov 9, 2009‎
The basic idea is to take a common protease inhibitor, Bristol-Myers Squibb's atazanavir (Reyataz), and swap out a few hydrogen atoms on the molecule with ... Xconomy

New Study Results Analyzed the Use of KAPIDEX(TM) (dexlansoprazole) for ...  -  ‎Oct 26, 2009‎
KAPIDEX must not be co-administered with atazanavir because atazanavir systemic concentrations may be substantially decreased. KAPIDEX may interfere with ... Reuters

B-MS posts strong sales for most of its drugs  -  ‎Oct 23, 2009‎
As for the firm's HIV drugs, sales of the Sustiva (efavirenz) franchise rose 7% to $315 million, and Reyataz (atazanavir) was up 5% to $360 million. ... Pharma Times

Gilead Sciences, Inc. Q3 2009 Earnings Call Transcript  -  ‎Oct 20, 2009‎
These are important data as they supported a Phase II study design of GS 9350 versus Ritonavir in combination with Atazanavir and Truvada in HIV-infected ... Seeking Alpha (blog)

FDA OKs Labeling Update for Reyataz Capsules  -  ‎Nov 9, 2009‎
Grade 2-4 treatment-related adverse events that occurred in 2 percent or greater of patients on the Reyataz (atazanavir sulfate)/r regimen, regardless of ... Trading Markets (press release)

BristolMyers Squibb Company Reports Operating Results (10-Q)  -  ‎Oct 22, 2009‎
Significant contributions to sales growth were also provided by the HIV portfolio (the SUSTIVA Franchise (efavirenz) and REYATAZ(atazanavir sulfate)), ... GuruFocus.com

Postexposure Prophylaxis for HIV Infection  -  ‎Oct 28, 2009‎
If a third drug is added, a protease inhibitor, often boosted with low-dose ritonavir (eg, ritonavir-boosted atazanavir, lopinavir, or darunavir), ... New England Journal of Medicine (subscription)

Market Watch  -  ‎Nov 5, 2009‎
The lower dose (2.5 mg) also is recommended for patients taking strong CYP3A4/5 inhibitors (eg, ketoconazole, atazanavir, clarithromycin, indinavir, ... The Hospitalist Online

Lower Norvir Boosting Dose Possible  -  ‎Oct 29, 2009‎
Hill and his colleagues also looked at studies with lopinavir (combined with ritonavir in Kaletra), Reyataz (atazanavir), Crixivan (indinavir) and Aptivus ... AIDSmeds.com HIV/AIDS Treatment News

New drug for type 2 diabetes  -  ‎Oct 29, 2009‎
Interactions: Potentiated by strong CYP3A4/5 inhibitors (eg, ketoconazole, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ... Clinical Advisor

Atazanavir et lithiases urinaires  -  ‎Nov 2, 2009‎
La spectrophotométrie a mis en évidence des cristaux d'atazanavir dans les calculs. La rédaction de Prescrire souligne l'importance d'une surveillance ... vih.org

Denuncian falta de stock de medicamentos contra el Sida en la Región  -  ‎Oct 28, 2009‎
Uno de los fármacos utilizados en contra de los males del SIDA, el Atazanavir, no estaría disponible desde hace quince días en los hospitales de la Región ... VmasV Noticias Valparaíso

[ë?™ì •]박완범 êµ?수, 국제젊ì?€ 연구ìž?ìƒ? 수ìƒ?  -  ‎Nov 6, 2009‎
...박완범 êµ?수는 'clinical and genetic factors influencing severe atazanavir-induced hyperbilirubinemia in Korean HIV patients'ë?¼ëŠ” 제목ì?˜ 논문으로 2006ë…„ì—? ... 메디팜뉴스

VIH: Desabastecimiento Es un Delito  -  ‎Oct 28, 2009‎
Según medios locales desde hace 15 días hay problemas de stock del fármaco conocido como Atazanavir en los hospitales de Antofagasta, Valparaíso, ... Chile.com

El 37% de los españoles infectados por el VIH es diagnosticado tarde  -  ‎Oct 21, 2009‎
Estas dos opciones, junto con atazanavir, son tres tipos de monoterapia con inhibidores de la proteasa que "han demostrado ser una estrategia simplificada ... elmundo.es

中国医è?¯äº§ä¸šç«žäº‰åŠ›æž„å»ºä¸Žå?¯æŒ?ç»­å?‘展  -  ‎Nov 2, 2009‎
...其中有国产的包括:阿扎那韦 (Atazanavir),2014å¹´1月美国专利到期;奈韦拉平(Nevirapine),2011å¹´11月美国专利到期;å?Œæ ·å°†äºŽ2011å¹´11月美国专利到期的还有HIV ... 中国生物技术信息网





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy